TABLE 1.
Kinetic characteristics of strains with Asn-221 of cytochrome b modified
| Strain | Photosynthetic growth | Reduction of heme bHa | Fraction of bH reducedb | Oxidation of heme bHc | Reoxidation (t1/2/ms)d |
|---|---|---|---|---|---|
| Wild type | +++ | 455 | <0.05 | >353 | <1.6 |
| N221D | +++ | Similar to wild typee | 0.8 | 15 | |
| N221H | +++ | 420 | 0.68 | 75 | 12 |
| N221P | +++ | 442 | 0.167 | 342 | 2.0 |
| N221S | +++ | Similar to wild type | 0.5 | 10.0 | |
| N221T | +++ | Similar to wild type | 0.37 | 8.0 | |
| N221I | +++ | Similar to wild type | 0.75 | 14 |
Rate of reduction of heme bH measured following a 5-μs flash at Eh ~ 120 mV in the presence of antimycin (units, mol of cytochrome bH/mol of bc1 complex/s) (see Fig. 4 for experimental details).
Fraction of heme bH reduced at the maximal amplitude of the kinetic trace in the absence of antimycin, compared with the fraction reduced in the presence of antimycin.
Rate of reoxidation of heme bH in the absence of antimycin, measured by subtraction of the traces in the presence and absence of antimycin (units, mol of cytochrome bH/mol of bc1 complex/s). The rate in the wild-type reflects the rate-limiting reduction of the low potential chain through the Qo-site reaction. Since v = k(occupancy), and the fraction of heme bH in the reduced form (column 4) is <<1, the rate constant must be much greater than that for the limiting step.
Half-times for reoxidation of heme bH were measured from kinetic traces.
Rates of Qo-site turnover were similar to wild-type, as judged by kinetics measured over a longer time scale. In some strains the rates measured in the presence of antimycin were inhibited compared with the rates without inhibitor because of a dramatic lowering of the Em of heme bH in the presence of antimycin. In these strains, the turnover of the Qo-site was estimated from the rate in the absence of antimycin, since the degree of inhibition allowed a significant reduction. The kinetic and thermodynamic properties of the mutant strains are described in detail elsewhere (29) (J. T. Holland, V. P. Shinkarev, and A. R. Crofts, manuscript in preparation).